320 related articles for article (PubMed ID: 18554753)
1. Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity.
Andrighetti-Fröhner CR; de Oliveira KN; Gaspar-Silva D; Pacheco LK; Joussef AC; Steindel M; Simões CM; de Souza AM; Magalhaes UO; Afonso IF; Rodrigues CR; Nunes RJ; Castro HC
Eur J Med Chem; 2009 Feb; 44(2):755-63. PubMed ID: 18554753
[TBL] [Abstract][Full Text] [Related]
2. Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR).
Bello ML; Chiaradia LD; Dias LR; Pacheco LK; Stumpf TR; Mascarello A; Steindel M; Yunes RA; Castro HC; Nunes RJ; Rodrigues CR
Bioorg Med Chem; 2011 Aug; 19(16):5046-52. PubMed ID: 21757358
[TBL] [Abstract][Full Text] [Related]
3. Leishmania amazonensis growth inhibitors: biological and theoretical features of sulfonamide 4-methoxychalcone derivatives.
Souza AM; Castro HC; Brito MA; Andrighetti-Fröhner CR; Magalhães U; Oliveira KN; Gaspar-Silva D; Pacheco LK; Joussef AC; Steindel M; Simões CM; Santos DO; Albuquerque MG; Rodrigues CR; Nunes RJ
Curr Microbiol; 2009 Oct; 59(4):374-9. PubMed ID: 19629593
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of chalcone analogues with increased antileishmanial activity.
Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B
Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
Agarwal KC; Sharma V; Shakya N; Gupta S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review of chalcone derivatives as antileishmanial agents.
de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
Peyron C; Benhida R; Bories C; Loiseau PM
Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro evaluation, and SAR studies of a potential antichagasic 1H-pyrazolo[3,4-b]pyridine series.
Dias LR; Santos MB; Albuquerque Sd; Castro HC; de Souza AM; Freitas AC; DiVaio MA; Cabral LM; Rodrigues CR
Bioorg Med Chem; 2007 Jan; 15(1):211-9. PubMed ID: 17064907
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
14. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of scorpiand-like azamacrocycle derivatives in promastigotes and intracellular amastigotes of Leishmania infantum and Leishmania braziliensis.
Marín C; Clares MP; Ramírez-Macías I; Blasco S; Olmo F; Soriano C; Verdejo B; Rosales MJ; Gomez-Herrera D; García-España E; Sánchez-Moreno M
Eur J Med Chem; 2013 Apr; 62():466-77. PubMed ID: 23395967
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation.
Rodrigues RF; da Silva EF; Echevarria A; Fajardo-Bonin R; Amaral VF; Leon LL; Canto-Cavalheiro MM
Eur J Med Chem; 2007 Jul; 42(7):1039-43. PubMed ID: 17367894
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-methyl-1,2,3,4-tetrahydroquinolines.
Pagliero RJ; Lusvarghi S; Pierini AB; Brun R; Mazzieri MR
Bioorg Med Chem; 2010 Jan; 18(1):142-50. PubMed ID: 19942439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
